These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31732448)

  • 1. Pooled Dosing and Efficacy Analysis of the Sufentanil Sublingual Tablet 30 mcg Across Demographic Subgroups for the Management of Moderate-to-Severe Acute Pain.
    Hutchins JL; Leiman D; Rafique Z; DiDonato KP; Palmer PP
    J Perianesth Nurs; 2020 Feb; 35(1):22-28. PubMed ID: 31732448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An up-to-date overview of sublingual sufentanil for the treatment of moderate to severe pain.
    Porela-Tiihonen S; Kokki H; Kokki M
    Expert Opin Pharmacother; 2020 Aug; 21(12):1407-1418. PubMed ID: 32486875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pooled Phase III safety analysis of sufentanil sublingual tablets for short-term treatment of moderate-to-severe acute pain.
    Miner JR; Melson TI; Leiman D; Minkowitz HS; Chiang YK; DiDonato KP; Palmer PP
    Pain Manag; 2019 May; 9(3):259-271. PubMed ID: 30614379
    [No Abstract]   [Full Text] [Related]  

  • 4. Sufentanil Sublingual Tablet: A New Option for Acute Pain Management.
    Reardon CE; Kane-Gill SL; Smithburger PL; Dasta JF
    Ann Pharmacother; 2019 Dec; 53(12):1220-1226. PubMed ID: 31280585
    [No Abstract]   [Full Text] [Related]  

  • 5. Sufentanil sublingual tablet 30mcg for moderate-to-severe acute pain in the ED.
    Miner JR; Rafique Z; Minkowitz HS; DiDonato KP; Palmer PP
    Am J Emerg Med; 2018 Jun; 36(6):954-961. PubMed ID: 29122372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Open-Label Study of Sufentanil Sublingual Tablet 30 Mcg in Patients with Postoperative Pain.
    Hutchins JL; Leiman D; Minkowitz HS; Jove M; DiDonato KP; Palmer PP
    Pain Med; 2018 Oct; 19(10):2058-2068. PubMed ID: 29126259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sufentanil Sublingual Tablet 30 mcg for the Management of Pain Following Abdominal Surgery: A Randomized, Placebo-Controlled, Phase-3 Study.
    Minkowitz HS; Leiman D; Melson T; Singla N; DiDonato KP; Palmer PP
    Pain Pract; 2017 Sep; 17(7):848-858. PubMed ID: 27781372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sufentanil 30 µg Sublingual Tablet: A Review in Acute Pain.
    Deeks ED
    Clin Drug Investig; 2019 Apr; 39(4):411-418. PubMed ID: 30887417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sufentanil sublingual tablet system for the management of postoperative pain.
    Babazade R; Turan A
    Expert Opin Pharmacother; 2016 Dec; 17(17):2351-2357. PubMed ID: 27796147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world use of the sufentanil sublingual tablet system for patient-controlled management of acute postoperative pain: a prospective noninterventional study.
    Pogatzki-Zahn E; Kranke P; Winner J; Weyland W; Reich A; Vigelius-Rauch U; Paland M; Löhr T; Eberhart L
    Curr Med Res Opin; 2020 Feb; 36(2):277-284. PubMed ID: 31612723
    [No Abstract]   [Full Text] [Related]  

  • 11. A dose-finding study of sufentanil sublingual microtablets for the management of postoperative bunionectomy pain.
    Singla NK; Muse DD; Evashenk MA; Palmer PP
    J Trauma Acute Care Surg; 2014 Sep; 77(3 Suppl 2):S198-203. PubMed ID: 25159356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sufentanil Sublingual Tablet System: from rationale of use to clinical practice.
    Vergari A; Cortegiani A; Rispoli M; Coluzzi F; Deni F; Leykin Y; Luca Lorini F; Martorano PP; Paolicchi A; Polati E; Scardino M; Corcione A; Giarratano A; Rossi M
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11891-11899. PubMed ID: 33275260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic properties of single- and repeated-dose sufentanil sublingual tablets in healthy volunteers.
    Willsie SK; Evashenk MA; Hamel LG; Hwang SS; Chiang YK; Palmer PP
    Clin Ther; 2015 Jan; 37(1):145-55. PubMed ID: 25544247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sufentanil sublingual tablet system for the management of postoperative pain following open abdominal surgery: a randomized, placebo-controlled study.
    Ringold FG; Minkowitz HS; Gan TJ; Aqua KA; Chiang YK; Evashenk MA; Palmer PP
    Reg Anesth Pain Med; 2015; 40(1):22-30. PubMed ID: 25318408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of sublingual sufentanil tablets and efficacy and safety in the management of postoperative pain.
    Minkowitz HS; Singla NK; Evashenk MA; Hwang SS; Chiang YK; Hamel LG; Palmer PP
    Reg Anesth Pain Med; 2013; 38(2):131-9. PubMed ID: 23271030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of sufentanil and the sufentanil sublingual tablet system for acute moderate to severe pain.
    Minkowitz HS
    Pain Manag; 2015; 5(4):237-50. PubMed ID: 26088280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient and Healthcare Professional Satisfaction Ratings and Safety Profile of Sufentanil Sublingual Tablets for Treatment of Acute Pain: A Pooled Demographic Analysis.
    Leiman D; Jové M; Spahn GR; Palmer P
    J Pain Res; 2021; 14():805-813. PubMed ID: 33790642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of sublingual sufentanil for postoperative pain management.
    van de Donk T; Ward S; Langford R; Dahan A
    Anaesthesia; 2018 Feb; 73(2):231-237. PubMed ID: 29219169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sufentanil Sublingual Tablet System for the Management of Postoperative Pain after Knee or Hip Arthroplasty: A Randomized, Placebo-controlled Study.
    Jove M; Griffin DW; Minkowitz HS; Ben-David B; Evashenk MA; Palmer PP
    Anesthesiology; 2015 Aug; 123(2):434-43. PubMed ID: 26079801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sufentanil sublingual formulation for the treatment of acute, moderate to severe postoperative pain in adult patients.
    Porela-Tiihonen S; Kokki M; Kokki H
    Expert Rev Neurother; 2017 Feb; 17(2):101-111. PubMed ID: 27835931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.